SR Medical Technology sets 31 Aug 2026 board meeting to approve H1 2026 results and consider dividend

Bulletin Express

Aug 19

SR Medical Technology Company Limited announced that its board of directors will convene on 31 August 2026. The agenda includes:

• Reviewing and approving the interim results for the six months ended 30 June 2026 and authorising their publication.

• Considering the declaration, recommendation, or payment of a dividend, if any.

The announcement was signed by Chairman Wei Chunxian on 19 August 2026. As of that date, the board comprised five executive directors—Wei Chunxian, Wei Laier, Sun Zhongmin, Chen Henan, and Liu Bingyang—and three independent non-executive directors—Tung Woon Cheung Eric, To Tsz Wan Vivien, and Huang Yining.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.etasphere.com/news/1185801129"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1185801129\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1185801129?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-19 19:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1185801129","market":"us","top_or_hot":-1,"title":"SR Medical Technology sets 31 Aug 2026 board meeting to approve H1 2026 results and consider dividend","media":"Bulletin Express","content":"<p>SR Medical Technology Company Limited announced that its board of directors will convene on 31 August 2026. The agenda includes:</p>\n<p>• Reviewing and approving the interim results for the six months ended 30 June 2026 and authorising their publication.</p>\n<p>• Considering the declaration, recommendation, or payment of a dividend, if any.</p>\n<p>The announcement was signed by Chairman Wei Chunxian on 19 August 2026. As of that date, the board comprised five executive directors—Wei Chunxian, Wei Laier, Sun Zhongmin, Chen Henan, and Liu Bingyang—and three independent non-executive directors—Tung Woon Cheung Eric, To Tsz Wan Vivien, and Huang Yining.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SR Medical Technology sets 31 Aug 2026 board meeting to approve H1 2026 results and consider dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSR Medical Technology sets 31 Aug 2026 board meeting to approve H1 2026 results and consider dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-19 19:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SR Medical Technology Company Limited announced that its board of directors will convene on 31 August 2026. The agenda includes:</p>\n<p>• Reviewing and approving the interim results for the six months ended 30 June 2026 and authorising their publication.</p>\n<p>• Considering the declaration, recommendation, or payment of a dividend, if any.</p>\n<p>The announcement was signed by Chairman Wei Chunxian on 19 August 2026. As of that date, the board comprised five executive directors—Wei Chunxian, Wei Laier, Sun Zhongmin, Chen Henan, and Liu Bingyang—and three independent non-executive directors—Tung Woon Cheung Eric, To Tsz Wan Vivien, and Huang Yining.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00108","symbol_name":"春雨医疗","start_time":0,"source_url":"","article_id":"1185801129","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1185801129","pubTimestamp":1787139981,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"SR Medical Technology Company Limited announced that its board of directors will convene on 31 August 2026. The agenda includes: • Reviewing and approving the interim results for the six months ended...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00108":"春雨医疗"},"translate_title":"SR Medical Technology 定于 2026 年 8 月 31 日召开董事会会议，批准 2026 年上半年业绩并考虑派发股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00108":1},"content_text":"SR Medical Technology Company Limited announced that its board of directors will convene on 31 August 2026. The agenda includes:\n• Reviewing and approving the interim results for the six months ended 30 June 2026 and authorising their publication.\n• Considering the declaration, recommendation, or payment of a dividend, if any.\nThe announcement was signed by Chairman Wei Chunxian on 19 August 2026. As of that date, the board comprised five executive directors—Wei Chunxian, Wei Laier, Sun Zhongmin, Chen Henan, and Liu Bingyang—and three independent non-executive directors—Tung Woon Cheung Eric, To Tsz Wan Vivien, and Huang Yining.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}